James Panek
Direktor/Vorstandsmitglied bei SUTRO BIOPHARMA, INC.
Vermögen: - $ am 30.04.2024
Aktive Positionen von James Panek
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SUTRO BIOPHARMA, INC. | Direktor/Vorstandsmitglied | 07.01.2020 | - |
Independent Dir/Board Member | 07.01.2020 | - | |
Cho Plus, Inc. | Geschäftsführer | - | - |
Karriereverlauf von James Panek
Ehemalige bekannte Positionen von James Panek
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
DIADEXUS, INC. | Direktor/Vorstandsmitglied | 01.01.2007 | 01.01.2011 |
Vorstandsvorsitzender | 01.01.2010 | 01.01.2011 | |
Finanzdirektor/CFO | 01.01.2010 | 01.01.2011 | |
Präsident | 01.01.2010 | 01.01.2011 | |
diaDexus, Inc. /Old/
diaDexus, Inc. /Old/ Medical SpecialtiesHealth Technology diaDexus is a privately held biotechnology company that is focused on the discovery, development and commercialization of novel, patent protected diagnostic products with high clinical value. diaDexus makes a difference by developing innovative products with clinical value to address significant unmet medical needs in the cardiovascular field. | Direktor/Vorstandsmitglied | 10.08.2010 | 01.11.2010 |
VaxGen, Inc.
VaxGen, Inc. BiotechnologyHealth Technology VaxGen, Inc. is a biopharmaceutical company, owns a state-of-the-art biopharmaceutical manufacturing facility that can be used to make cell culture or microbial biologic products. The company has ended all product development activities and sold or otherwise terminated its drug development programs. It is seeking to maximize the value of its remaining tangible and intangible assets through a transaction or series of transactions, including the sale of the manufacturing facility. The company was founded on November 01, 1995 and is headquartered in South San Francisco, CA. | Comptroller/Controller/Auditor | 01.01.2007 | 01.01.2010 |
Direktor/Vorstandsmitglied | 01.01.2007 | 01.01.2010 | |
Finanzdirektor/CFO | 01.01.2007 | 01.01.2010 | |
Corporate Officer/Principal | 01.02.2002 | 01.01.2006 | |
Präsident | 01.01.2007 | 01.01.2010 | |
CELLTRION, INC. | Vorstandsvorsitzender | 01.01.2002 | 01.01.2006 |
Vorsitzender | 01.01.2002 | 01.01.2006 | |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01.01.1982 | 01.01.2001 |
Ausbildung von James Panek
University of Michigan | Graduate Degree |
Statistik
International
Vereinigte Staaten | 8 |
Südkorea | 2 |
Operativ
Director/Board Member | 4 |
Director of Finance/CFO | 2 |
Corporate Officer/Principal | 2 |
Sektoral
Health Technology | 7 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
SUTRO BIOPHARMA, INC. | Health Technology |
CELLTRION, INC. | Health Technology |
Private Unternehmen | 5 |
---|---|
VaxGen, Inc.
VaxGen, Inc. BiotechnologyHealth Technology VaxGen, Inc. is a biopharmaceutical company, owns a state-of-the-art biopharmaceutical manufacturing facility that can be used to make cell culture or microbial biologic products. The company has ended all product development activities and sold or otherwise terminated its drug development programs. It is seeking to maximize the value of its remaining tangible and intangible assets through a transaction or series of transactions, including the sale of the manufacturing facility. The company was founded on November 01, 1995 and is headquartered in South San Francisco, CA. | Health Technology |
diaDexus, Inc. /Old/
diaDexus, Inc. /Old/ Medical SpecialtiesHealth Technology diaDexus is a privately held biotechnology company that is focused on the discovery, development and commercialization of novel, patent protected diagnostic products with high clinical value. diaDexus makes a difference by developing innovative products with clinical value to address significant unmet medical needs in the cardiovascular field. | Health Technology |
Diadexus, Inc.
Diadexus, Inc. BiotechnologyHealth Technology Diadexus, Inc. engages in the research, development, and commercialization of pharmaceutical products. Its portfolio intends to treat cardiovascular diseases. The company was founded on November 27, 1995 and is headquartered in South San Francisco, CA. | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Cho Plus, Inc. |
- Börse
- Insiders
- James Panek
- Erfahrung